This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Scripps Research Discovers...
Tech medical breakthrough

Scripps Research Discovers Alzheimer's Blood Test

Analysis based on 9 articles · First reported Mar 09, 2026 · Last updated Mar 11, 2026

Sentiment
70
Attention
6
Articles
9
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

This medical breakthrough by Scripps Research could significantly impact the biotechnology and pharmaceutical markets by enabling earlier diagnosis and potentially more effective treatments for Alzheimer s disease. It opens new avenues for investment in diagnostic technologies and drug development targeting protein structure.

Biotechnology Pharmaceutical Healthcare
Event Summary

Researchers at Scripps Research have discovered that subtle structural changes in three blood proteins (C1QA, Clusterin, and Apolipoprotein B) can identify Alzheimer s disease and mild cognitive impairment with remarkable accuracy, reaching over 93% accuracy in differentiating healthy adults from those with MCI. The study, published in List of Nature Research journals, demonstrates that examining the structure and shape of proteins in the bloodstream, rather than just their quantity, provides powerful predictive markers. This breakthrough offers a new approach for early detection, monitoring disease progression, and measuring treatment effects, potentially revolutionizing the fight against Alzheimer s disease and other neurodegenerative conditions like Parkinson's and cancer.

Key Actions
100 Scripps Research discovered a new diagnostic method for Alzheimer s disease
85 John Yates (chemist) led research on protein structure changes as predictive markers
70 Casimir Bamberger co-authored the study on protein structural differences
Entities Involved
ngo
Scripps Research
Scripps Research discovered that subtle structural changes in three blood proteins can identify Alzheimer s disease and mild cognitive impairment with remarkable accuracy. This breakthrough could lead to new diagnostic tools and treatments, enhancing Scripps Research's reputation and potential for future collaborations.
Importance 90 Sentiment 75
per
John Yates (chemist)
As a senior author of the study at Scripps Research, John Yates_(chemist) played a pivotal role in the discovery of protein structural changes as predictive markers for neurodegenerative diseases. His work highlights the importance of understanding proteostasis.
Importance 80 Sentiment 70
per
Casimir Bamberger
As a senior scientist at Scripps Research and co-author, Casimir Bamberger contributed to the study's findings, noting the incredible correlation between specific protein sites and disease state. His involvement underscores the collaborative nature of the research.
Importance 70 Sentiment 65
Relationships
John Yates (chemist) related ↔ Scripps Research
Casimir Bamberger related ↔ Scripps Research
John Yates (chemist) related ↔ Casimir Bamberger
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.